罗莫苏祖马布在因停用德诺苏祖马布引起的反弹脊椎骨折后:一个案例系列
Marcelo Sarli1, Vanina Farias1, Rubén Abdala1
1Department of Endocrinology, IDIM, Buenos Aires, C1012AAR, Argentina.
JBMR plus
|January 12, 2026
概括
停止服用德诺苏马布可能会导致反弹骨折. 在四名患有后代诺苏马布骨折的患者中,罗莫苏马布治疗改善了骨密度和微观结构,这表明它是潜在的治疗方法.
科学领域:
- 骨生物学和骨质疏松症研究研究
- 对于骨疾病的药理干预措施
背景情况:
- 停止服用德诺苏马布可以引发骨再吸收的反弹增加.
- 这种反弹效应可能导致严重的后果,包括多重脊椎骨折.
- 目前的指导方针建议重新治疗denosumab或zoledronate来控制这种反弹现象.
研究的目的:
- 为了评估romosozumab在患者经历脊椎骨折后denosumab撤销后的疗效.
- 评估romosozumab对骨矿物质密度 (BMD),微架构和骨周转率标记物的影响,在这个特定的患者群体中.
主要方法:
- 分析了4名患者的病例系列,这些患者在停止使用denosumab后出现了脊椎骨折.
- 随后,患者接受了双重作用剂罗莫苏祖马布的治疗.
- 监测了包括BMD,微架构,骨周转标志物和新骨折发生率在内的结果.
主要成果:
- 在罗莫苏祖马布治疗期间,所有四名患者都在骨硬化和骨微型架构方面呈现出逐步改善.
- 骨循环标记被抑制,表明骨的再吸收减少.
- 在治疗和随访期间没有出现新的临床骨折.
结论:
- 罗莫苏祖马布可能是一个可行的治疗选择,在患者经历脊椎骨折后,德诺苏祖马布撤销.
- 这些发现虽然是初步的,因为样本规模小,设计不受控制,但需要进一步调查.
- 罗莫苏马布的双重合成代谢和抗吸收作用可能有助于控制德诺苏马布反弹效应.
相关概念视频
01:40Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
01:27Fractures: Bone Repair
4.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
4.9K
01:31Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K